MedTrace Logo

Eyes On Lips? Speechreading Skills and Facial Expression Discrimination in Children With and Without Impaired Hearing

NCT05854719 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-01-08

No results posted yet for this study

Summary

The goal of this clinical trial is to find out the role of background factors and gaze use in children's speechreading performance.

The main questions it aims to answer are:

* Which background factors and eye gaze patterns are associated with the best speechreading results in hearing children and those with hearing impairment/loss?
* Are children's gaze patterns and facial expression discrimination associated with interpretation of emotional contents of verbal messages in speechreading?
* What is the efficacy of intervention that is based on the use of a speechreading application to be developed?

Participants will be

* tested with linguistic and cognitive tests and tasks
* tested with a speechreading test and tasks with or without simultaneous eye-tracking
* about half of the participants with hearing impairment/loss will train speechreading with an application

Researchers will compare the different age groups and the results of hearing children to those of children with impaired hearing to see if there are differences.

Conditions

Interventions

BEHAVIORAL

Speechreading training with an application

The Optic Track application developed for this intervention will be used in speechreading training. The target is that, during the eight intervention weeks, it would be used for 15 minutes at least three times a week.

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER

  • Tampere University

    collaborator OTHER

  • University of Oulu

    lead OTHER

Principal Investigators

  • Kerttu Huttunen, PhD · University of Oulu, Finland

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-12
Primary Completion
2025-12-12
Completion
2025-12-12

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05854719 on ClinicalTrials.gov